Vitalhub Corp. (TSE:VHI) Given Average Rating of “Buy” by Brokerages

Shares of Vitalhub Corp. (TSE:VHI) have earned a consensus rating of “Buy” from the seven analysts that are presently covering the firm, Marketbeat reports. Six research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month target price among brokers that have covered the stock in the last year is C$13.14.

VHI has been the subject of several research reports. Raymond James Financial reduced their price target on shares of Vitalhub from C$15.00 to C$11.00 and set an “outperform” rating for the company in a research report on Tuesday, March 24th. National Bank Financial lowered their price objective on shares of Vitalhub from C$14.00 to C$11.00 and set an “outperform” rating on the stock in a research note on Wednesday, May 27th.

Vitalhub Price Performance

Shares of TSE:VHI traded down C$0.06 during trading on Monday, hitting C$6.89. 87,390 shares of the company were exchanged, compared to its average volume of 352,668. The stock has a market capitalization of C$435.86 million, a P/E ratio of 57.42, a PEG ratio of 1.18 and a beta of 0.91. Vitalhub has a 12-month low of C$6.62 and a 12-month high of C$14.64. The firm’s 50 day moving average price is C$7.21 and its 200-day moving average price is C$7.77.

Vitalhub (TSE:VHI) last issued its quarterly earnings data on Thursday, May 7th. The company reported C$0.04 earnings per share for the quarter. The business had revenue of C$31.91 million during the quarter. Vitalhub had a net margin of 6.13% and a return on equity of 2.98%. As a group, equities research analysts anticipate that Vitalhub will post 0.2296467 EPS for the current year.

Vitalhub Company Profile

VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub’s comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,300 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 700 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka.